Bodor JN, Bauman JR, Handorf EA, Ross EA, et al. Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy. J Cancer Res Clin Oncol 2022 Jun 16. pii: 10.1007/s00432-022-04089.
PMID: 35708776